Incyte Corp (INCY)
69.56
-0.35
(-0.50%)
USD |
NASDAQ |
Dec 26, 16:00
70.14
+0.58
(+0.83%)
After-Hours: 05:25
Incyte Cash from Investing (Quarterly): 38.27M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | -16.16M |
| Pfizer Inc | -2.057B |
| Exelixis Inc | -217.15M |
| Insmed Inc | -1.003B |
| Sage Therapeutics Inc | 81.05M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 310.87M |
| Cash from Financing (Quarterly) | -32.35M |
| Free Cash Flow | 16.80M |
| Free Cash Flow Per Share (Quarterly) | 1.497 |
| Free Cash Flow to Equity (Quarterly) | 293.18M |
| Free Cash Flow to Firm (Quarterly) | 293.18M |
| Free Cash Flow Yield | 0.11% |